Unknown PHASE3 INTERVENTIONAL 2-arm NCT03696940

Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina

Sponsor: Instituto Nacional de Salud Publica, Mexico

Conditions Cardiovascular Risk Factor Dyslipidemias

Interventions Atorvastatin 10mg L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg

Updated 6 times since 2018 Last updated: Feb 25, 2019 Started: May 28, 2018 Primary completion: Mar 1, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cardiovascular Risk Factor and Dyslipidemias, this trial is ongoing. The trial is conducted by Instituto Nacional de Salud Publica, Mexico and has accumulated 6 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting PHASE3
Mar 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

▶ Show 1 earlier version

Nov 2018 — Mar 2019 [monthly]

Active Not Recruiting PHASE3

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Salud Publica, Mexico
Laboratorios Grossman, S.A.

Data source: Laboratorios Grossman, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico